← Back to work
Works cited by this work
62 works
Work: Treatment of Parkinson’s Disease with an Anti-Inflammasome NLRP3 Inhibitor Derived from a Natural Product
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov, Sergey B. Zotchev, Verena M. Dirsch +71
Review article20217 citationsABIInflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser +3
Review article20225 citationsABIParkinson's disease
Bastiaan R. Bloem, Michael S. Okun, Christine Klein
Review article20214 citationsABINLRP3 inflammasome in cancer and metabolic diseases
Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Review article20214 citationsABIEmerging role of natural products in cancer immunotherapy
Songtao Dong, Xiangnan Guo, Fei Han +2
Review article20213 citationsABIα-Synuclein misfolding and Parkinson's disease
Leonid Breydo, Jessica Wu, Vladimir N. Uversky
Review article20113 citationsABIMicroglia Function in the Central Nervous System During Health and Neurodegeneration
Review article20172 citationsABITwenty years on: the impact of fragments on drug discovery
Daniel A. Erlanson, Stephen W. Fesik, Roderick E. Hubbard +2
Review article20162 citationsABITeaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives
Review article20222 citationsABIInflammation in obesity, diabetes, and related disorders
Theresa V. Rohm, Daniel T. Meier, Jerrold M. Olefsky +1
Review article20222 citationsABIThe NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson, Meng Deng, Jenny P.‐Y. Ting
Review article20192 citationsABIEpidemiology of Parkinson’s disease
Ole‐Bjørn Tysnes, Anette Storstein
Review article20172 citationsABI